Thu, Feb. 19, 10:28 AM
- Thinly-traded nano cap CollabRx (CLRX +98.2%) jumps on a massive 19x surge in volume, recovering from a short-term sell-off after its initial breakout. Shares are up 132% since breaking out on February 2 in response to a potential merger with Medytox.
- Previously: CollabRx up on improved funding outlook from potential business combo (Feb. 2)
Mon, Feb. 2, 12:02 PM| Comment!
CLRX vs. ETF Alternatives
CollabRx Inc is a data analytics company. It is engaged in developing and delivering knowledge-based products and services that inform healthcare decision-making, with an emphasis on genomics-based 'precision' medicine and big data analytics.
Other News & PR